Covered recipient · General Payments record
JESSICA K SEARS
Allopathic & Osteopathic Physicians Family Medicine Adult Medicine
General Payments · PY2021–2024
$1,089.49
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $523.37 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $324.58 | 14 |
| Galderma Laboratories, L.P. | $137.05 | 2 |
| REVANCE THERAPEUTICS, INC. | $61.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.88 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050118 | CMS |
| ABBVIE INC. | $18.92 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050120 | CMS |
| ABBVIE INC. | $7.16 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050122 | CMS |
| ABBVIE INC. | $25.78 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050124 | CMS |
| ABBVIE INC. | $17.17 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050126 | CMS |
| ABBVIE INC. | $20.97 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050128 | CMS |
| ABBVIE INC. | $46.60 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050130 | CMS |
| ABBVIE INC. | $13.24 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050132 | CMS |
| ABBVIE INC. | $97.42 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050134 | CMS |
| ABBVIE INC. | $18.00 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050136 | CMS |
| ABBVIE INC. | $4.89 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050138 | CMS |
| ABBVIE INC. | $25.18 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050140 | CMS |
| ABBVIE INC. | $2.55 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050142 | CMS |
| ABBVIE INC. | $8.82 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106050144 | CMS |
| Galderma Laboratories, L.P. | $39.00 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145391083 | CMS |
| Galderma Laboratories, L.P. | $98.05 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145391085 | CMS |
| REVANCE THERAPEUTICS, INC. | $61.74 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147950696 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.